HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uncontrolled gelatin degradation in non-healing chronic wounds.

AbstractOBJECTIVE:
To compare matrix metalloproteinase (MMP)-9 and the antiproteinase tissue inhibitor of metalloproteinases (TIMP)-1 in wound fluids and sera from patients with chronic non-healing or acute healing wounds. In addition, the functional consequences on MMP-9 activity and general gelatinase activity were assessed.
METHOD:
In this observational study, samples were collected from patients with venous leg ulcers (VLUs), patients with type 2 diabetes with neuropathic foot ulcers (DFUs), and from another cohort of VLU patients with sterile split-thickness skin graft donor sites after autologous skin grafting, serving as healing control wounds. MMP-9 and TIMP-1 concentrations were determined by enzyme-linked immunosorbent assays. MMP-9 and gelatinase activities were determined in wound fluids in subsets of the patients.
RESULTS:
A total of 24 patients took part in the study. No significant differences in MMP-9 wound fluid levels were found among the three groups. TIMP-1 levels were markedly and significantly lower in the two chronic wound groups resulting in a severely unbalanced MMP-9/TIMP-1 ratio, especially notable in the VLU group and possibly in the elevated endogenous MMP-9 activity (p<0.01) compared with the acute wound fluids. At least 20% of the chronic wound fluids displayed atypical patterns on gelatin zymography and showed high general gelatinase activity that was not inhibited by either TIMP-1 or by a gelatinase inhibitor (AG3340). MMP-9 levels were higher in the sera of the patients with type 2 diabetes.
CONCLUSION:
We hypothesise that non-MMP proteinases contribute to matrix destruction in a significant number of chronic wounds. Blocking the excessive MMP-9 activity may be insufficient to normalise wound healing. The reasons and effects of the very low TIMP-1 levels in chronic wounds need further clarification.
AuthorsHannah Trøstrup, Per Holstein, Tonny Karlsmark, Claus Moser, Magnus S Ågren
JournalJournal of wound care (J Wound Care) Vol. 27 Issue 11 Pg. 724-734 (11 02 2018) ISSN: 0969-0700 [Print] England
PMID30398935 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • TIMP1 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • Gelatin
  • Matrix Metalloproteinase 9
Topics
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Diabetes Mellitus, Type 2 (complications)
  • Diabetic Foot (metabolism, physiopathology)
  • Exudates and Transudates (chemistry)
  • Female
  • Gelatin (metabolism)
  • Humans
  • Male
  • Matrix Metalloproteinase 9 (blood)
  • Middle Aged
  • Tissue Inhibitor of Metalloproteinase-1 (blood)
  • Varicose Ulcer (metabolism, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: